Nighttime awakenings attributed to vasomotor symptoms were significantly reduced within @ weeks of initiating paroxetine @ mg treatment ( @ % reduction vs @ % for placebo ; P = @ ) , and reductions were sustained through @ or @ weeks of treatment .